STAT Plus: Congress asked the FDA to explain its rules on CBD — but its new report offers little clarity
WASHINGTON — A new report on cannabidiol, or CBD, from the Food and Drug Administration,…
Author: STAT
Progressives push Trump administration to ensure a future coronavirus vaccine is affordable
WASHINGTON — Progressive Democrats are pushing to constrain how much drug makers can charge for…
STAT Plus: Gene and cell therapies continue growth in patients, financing, and costs
The number of people treated with approved gene therapies and gene-modified cell therapies like CAR-T…
Covid-19 epidemic forces cancellation of HIMSS health tech conference
The health care technology trade group HIMSS has canceled its annual conference for the first…
STAT Plus: The Engine at MIT is revving up the potential of ‘tough tech’
If you happen to bump into Bill Gates or Tim Cook in Central Square in…
Opinion: Super Tuesday results suggest that Americans ‘aren’t looking for big structural changes’ in health care
Voters on Tuesday sent several messages, including a key one about health care. Big ideas…
Opinion: Coronavirus spending: an expense — or an investment?
In the context of a looming global pandemic, what does it mean to invest in…
STAT Plus: Pharmalittle: Coronavirus vaccine testing starts in Seattle area; New Mexico law caps monthly insulin co-pay at $25
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
How blood plasma from recovered patients could help treat the new coronavirus
When it comes to creating treatments for Covid-19, the disease caused by the novel coronavirus,…
Opinion: A coronavirus vaccine should be for everyone, not just those who can afford it
As the coronavirus that causes COVID-19 spreads in more than 60 countries, the race to…
Opinion: It will take a village to solve the epidemic of maternal deaths in the U.S.
The phrase “maternal deaths” tends to conjure up images of awful complications of delivery: uncontrollable…
From ferrets to mice and marmosets, labs scramble to find right animals for coronavirus studies
One lab is digging into its freezer to thaw out the archived sperm of SARS-susceptible…
Watch: Flu has a season, but will Covid-19 melt away with the spring? It’s not so simple
A new coronavirus, SARS-CoV-2, emerged during the Northern Hemisphere’s flu season. With spring approaching, some…
STAT Plus: Oh, Canada! Vertex battles another country over access to cystic fibrosis treatments
A row has broken out between Vertex Pharmaceuticals (VRTX) and Canadian officials over access to…
New surgery and AI give amputees more precise control of a prosthetic hand, study shows
People with limb injuries severe enough to require an amputation have few options to regain…
STAT Plus: What to expect at health tech’s big HIMSS conference — if it happens
An earlier version of this story appeared in STAT’s Health Tech newsletter. Click here to subscribe….
Opinion: Trump’s immigration policies will make the coronavirus pandemic worse
Pandemics have a way of testing us. Throughout history, societies have responded to plagues by…
.jpg)
In its first use inside the human body, CRISPR genome editing tested as blindness therapy
Scientists say they have used the gene editing tool CRISPR inside someone’s body for the…
STAT Plus: Pharmalittle: Vaccine affordability a roadblock to coronavirus funding; developing a drug costs how much?
Top of the morning to you and a fine one, it is. A shiny sun…
Opinion: How innovation is helping mitigate the coronavirus threat
The sudden emergence and rapid spread of a novel coronavirus, now called Covid-19, is a…
Opinion: Doctors need to embrace the ‘power of yet’
I believe in the power of yet. Doctors should, too, especially the one who used…
STAT Plus: This biotech went public during the stock market’s worst week since 2008
Concerns about the coronavirus outbreak made last week one of the markets’ worst since the…
See one woman’s complicated, costly journey to a Canadian strip mall pharmacy — all for cheaper insulin
Just after Emma Kleck turned 26, she started looking up flights to Canada. Kleck, who…
Washington State risks seeing explosion in coronavirus without dramatic action, new analysis says
The coronavirus outbreak in the Seattle area is at a critical juncture and could see…
Justice Department sues Mallinckrodt over ‘hundreds of millions of dollars’ in Medicaid rebates
A simmering feud between the federal government and Mallinckrodt (MNK) took a new turn as…
WHO: Coronavirus is different from influenza, and that means it can be contained
Top officials at the World Health Organization this week have sought to differentiate the spreading…
STAT Plus: TG Therapeutics cops to another blood cancer drug trial delay, as excuses wear thin
TG Therapeutics (TGTX) on Tuesday delayed yet again the readout from its most important blood…
STAT Plus: Drug prices rose three times faster than inflation over the past decade, despite discounts
Amid intensifying anger over the rising cost of medicines, a key piece of data has…
STAT Plus: New estimate says developing a drug costs $1.3 billion, which is a lot, but less than companies often say
Estimates of how much it cost to invent and test a new medicine have been…
STAT Plus: Thermo Fisher buys Dutch diagnostics company for $11.5 billion
Thermo Fisher Scientific (TMO) is buying the Dutch diagnostics company Qiagen (QGEN) in an $11.5…
STAT Plus: Pharmalittle: Trump’s contempt for pharma melts away; India restricts exports of 26 ingredients due to coronavirus
Rise and shine, everyone, another busy day is on the way. We can tell because…
The coronavirus could help pharma reset its reputation in Washington
WASHINGTON — The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation…
Opinion: Precision medicine: course correction urgently needed
An undeclared civil war is breaking out in biomedicine. On one side is precision medicine, with…
STAT Plus: Contract spells out how the University of Chicago shared patient data with Google
SAN FRANCISCO — In December 2016, Google and the University of Chicago signed a contract…
Who is getting sick, and how sick? A breakdown of coronavirus risk by demographic factors
The new coronavirus is not an equal-opportunity killer: Being elderly and having other illnesses, for…
Trump’s tone toward pharma shifts, as he looks to drug makers to help with coronavirus response
WASHINGTON — President Trump had billed the meeting with pharmaceutical executives as a scolding waiting…
STAT Plus: Novartis generic unit to pay $195 million to settle price fixing charges
In the latest fallout from a federal probe into generic drug price fixing, the Sandoz…
STAT Plus: California slams AmerisourceBergen over opioid shipments to pharmacies
The California Board of Pharmacy cancelled a wholesale license for AmerisourceBergen (ABC) and fined the…
A detailed guide to the coronavirus drugs and vaccines in development
In the months since the novel coronavirus rose from a regional crisis to a global…
STAT Plus: Cancer biotech gets another new name (now it’s called Xilio) and more than $100 million
For the second time in less than two years, Akrevia Therapeutics has changed its name, in…
STAT Plus: CEO Daniel O’Day explains why Gilead paid $4.9 billion for Forty Seven
Gilead’s board hired CEO Dan O’Day a year ago to look for new areas of…
STAT Plus: FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen
An online pharmacy is calling for U.S. regulators to recall batches of the metformin diabetes…
The coronavirus exposes our health care system’s weaknesses. We can be stronger
A coronavirus is so tiny that 1,000 of them could be stacked in the thickness…
STAT Plus: Pharmalittle: Experts warn political squabbles should not delay coronavirus funding; Gilead to buy Forty Seven for $5 billion
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Research in the time of coronavirus: keep it ethical
The sudden outbreak of Covid-19, a disease caused by a new coronavirus, is proving to…
STAT Plus: Karyopharm to seek expanded use of multiple myeloma drug following positive clinical trial
Karyopharm Therapeutics (KPTI) said Monday that the primary goal was achieved in a clinical trial…
When the hoofbeats really are a zebra’s, a patient community helps me navigate a new rare-disease reality
“I have some unexpected news.” That’s what the doctor said to me when my 10-month-old…
.jpg)
Partisan bickering delayed Zika funding for months. With coronavirus, experts worry history will repeat itself
WASHINGTON — Public health experts have a warning for Congress: don’t treat emergency coronavirus aid…
STAT Plus: Something Ventured: Vor Biopharma and 3 other startups got venture funding a year ago. Did it help them do what they said it would?
This story is part of STAT’s quarterly series Something Ventured, which looks at early-stage startups….
Welcome to STAT Madness
This is our fourth annual STAT Madness, a bracket-style tournament to find the best innovations…